Developer docs
API playgroundTry for free, no card

Search company profiles

EyeControl

Full company profile

uuid0002je5

Namestring
EyeControl
Legal namestring
Eyefree Assisting Communication Ltd.
Company typeenum
Private
Founded yearint
2016
Descriptiontext

EyeControl (legally Eyefree Assisting Communication Ltd.) is an Israel-based medical device company founded in 2016 that builds an adaptive communication platform combining specialized hardware and software for patients who cannot speak due to intubation, sedation, or neurological conditions such as ALS. The platform consists of a wearable headset that pairs bone conduction audio with an AI-assisted infrared eye-tracking camera, a bedside tablet hub that delivers interventions under sedation and supports active engagement during recovery, and a secure Family App for message, photo, and music sharing. The system requires no calibration, supports multilingual communication including cross-language input/output, and operates 24/7 with seamless sleep-mode transitions.

The company operates two distinct go-to-market motions. For hospitals and ICUs, EyeControl sells a platform subscription/licensing model with on-the-ground Clinical Product Specialists handling implementation, training, and adoption at the bedside. Named enterprise customers include major Israeli hospitals (Rabin/Beilinson, Assuta, Meir, Tel Aviv Sourasky, PIC), all four major Israeli HMOs (Clalit, Maccabi, Meuhedet, Leumit), and in the United States, Northwell Health. For ALS and degenerative-disease patients at home, the EyeControl Home product is distributed via field specialists and is fully subsidized by Israel's Ministry of Health, removing patient cost.

The business generates revenue from healthcare-facility subscriptions and from hardware sales (the headset and bedside tablet). EyeControl holds FDA 21 CFR Part 11 clearance, ISO 27001, HIPAA, and GDPR compliance, and has raised approximately $15.3M across disclosed rounds from investors including Connecticut Innovations, the European Innovation Council, BIRD Foundation, Menomadin Foundation, and ZORA Ventures.

Short descriptiontext

EyeControl is an Israel-based medical device company that builds AI-assisted eye-tracking headsets and bedside communication software enabling intubated, sedated, and ALS patients to communicate, serving hospitals and ICUs via enterprise subscriptions and home patients via Ministry of Health-subsidized distribution.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTel Aviv, Israel
HQ citystring
Tel Aviv
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
eye-tracking communication, medical assistive technology, ICU patient communication, ALS communication devices, wearable healthcare devices
Industry2 codes
PRIMARYHDACAFAL
Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards)
Hardware, Technology & Telecom/Computing Hardware & Peripherals/Input Devices & Accessories (Keyboards, Mice, Controllers)
SECONDARYHDACALAH
Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Computer Peripheral Equipment, Nec3577
Product category
Medical Communication Devices
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Healthcare Facility Licenses/Subscriptions
TypeSubscription Recurring
Description

Platform licensing or subscription model to hospitals and healthcare facilities for ICU and critical care communication support

eyecontrol.co.il
2EyeControl Home (Consumer/Home Health)
TypeHardware Sales
Description

Direct-to-patient home communication solution for ALS patients, subsidized by Israel's Ministry of Health

eyecontrol.co.il
3Hardware (Headset)
TypeHardware Sales
Description

Specialized headset device combining bone conduction audio with eye-tracking technology

eyecontrol.co.il
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1EyeControl Home - Ministry of Health Subsidized
ModelSubscriptionBilling cadenceAnnual
Notes

EyeControl Home communication solution for ALS and degenerative disease patients is fully subsidized by Israel's Ministry of Health, eliminating patient cost burden

eyecontrol.co.il
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1EyeControl Home
Description

Communication solution for patients with ALS and other degenerative diseases, fully subsidized by the Ministry of Health.

eyecontrol.co.il
Core offering1 text field

EyeControl develops an adaptive communication platform combining specialized wearable hardware (a headset with bone conduction audio and AI-powered infrared eye-tracking camera) with bedside tablet and family mobile app software. The platform enables patients who cannot speak due to intubation, sedation, ALS, or other neurological conditions to communicate through eye gestures, scan audio-based menus, and connect with medical teams and families across ICU/critical care and home environments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduces ICU patient agitation through calming input and communication
+3 more records
Product overview1 text field

EyeControl offers a unified adaptive communication platform designed for critical care and home use. The platform consists of specialized hardware components (Headset with bone conduction audio and AI-powered eye tracking, Bedside Tablet) and software (Family App) that work together to enable patients with complex needs to communicate. EyeControl Home extends the solution for home use by ALS patients. The platform supports patients from sedation through rehabilitation, providing 24/7 assistance with personalized and adaptable interaction modes.

Product and service3 records
1EyeControl Platform
CategoryCommunication Platform
Description

An adaptive communication platform combining specialized hardware (headset with bone conduction audio and AI-powered eye tracking, bedside tablet) and software (Family App) that supports patients from sedation through rehabilitation across hospital and home environments. Designed for ICU/critical care teams and patients with complex communication needs.

2EyeControl Headset
CategoryMedical Hardware Device
Description

A wearable FDA-cleared medical device combining bone conduction audio with an infrared eye-tracking camera to detect patient awareness and enable hands-free communication responses through eye gestures for sedated, intubated, or neurologically impaired patients.

3EyeControl Bedside Tablet
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Ministry of Health (Israel)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Israeli government health ministry subsidizes EyeControl Home solution for ALS patients, making it free for qualifying patients

eyecontrol.co.il
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Advisory board member Karen H. Thompson serves as AVP of Regional Community Engagement at HCA Healthcare

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Advisory board member Dr. Ariel Modrykamien serves at Medical ICU of Baylor University Medical Center

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Advisory board member Prof. Vivian Drory is a neurologist at Tel Aviv Sourasky Medical Center

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Vocera (acquired by Stryker) provides secure hands-free clinical communication and alarm management for hospitals, including ICU workflows. Broad incumbent in hospital clinical communication with overlapping ICU patient/staff communication use cases, though not focused on eye-tracking-based patient output.

TypeDirect peer
Description

EyeTech Digital Systems manufactures eye-tracking hardware and AAC integration solutions used in assistive communication and clinical research. Direct overlap in eye-tracking component technology for communication applications.

TypeDirect peer
Description

PRC-Saltillo (Prentke Romich Company / Saltillo) sells AAC devices including eye-tracking-based communicators (e.g., Accent 1000 with NuEye) for individuals with speech disabilities. Directly comparable to EyeControl in providing eye-gaze AAC solutions to non-speaking patients.

TypeEmerging player
Description

AssistiveWare produces Proloquo and Keeble AAC software, primarily on iPad, focused on autism, cerebral palsy, and progressive conditions. Less hardware-specialized than EyeControl but addresses a similar communication-needs population with iOS-based tools.

TypeDirect peer
Description

Lingraphica provides AAC devices and apps primarily for adults with aphasia and other communication disorders, often reimbursed through US insurance. Comparable in delivering speech-generating devices to non-verbal adult populations.

TypeDirect peer
Description

Tobii Dynavox is the dominant dedicated AAC (augmentative and alternative communication) vendor using eye-tracking hardware (Tobii eye trackers) and dedicated software for non-speaking individuals with ALS, cerebral palsy, and other conditions. It is the most direct competitor to EyeControl on assistive eye-tracking communication.

7Smartbox Assistive Technology
TypeDirect peer
Description

Smartbox (Grid/Communicator product line) builds AAC hardware and software, including eye-gaze-enabled devices for people with complex communication needs. Highly comparable in target population and modality.

TypeDirect peer
Description

LC Technologies (Eyegaze Edge) builds eye-tracking-based AAC systems for non-verbal users including those with ALS and locked-in syndrome. Direct peer in eye-gaze communication hardware and software.

TypeBroad incumbent
Description

Baxter (after acquiring Hillrom/Voalte) offers Voalte and Hillrom bedside communication platforms deployed in hospitals. Broad incumbent in hospital patient/staff communication infrastructure with overlapping ICU and patient-engagement applications.

TypeBroad incumbent
Description

Tobii AB, the parent of Tobii Dynavox, develops eye-tracking hardware and platforms across healthcare, research, and consumer applications. Comparable as an enabling technology supplier and broader eye-tracking presence.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EyeControl

Medical Communication Deviceseyecontrol.co.il

EyeControl is an Israel-based medical device company that builds AI-assisted eye-tracking headsets and bedside communication software enabling intubated, sedated, and ALS patients to communicate, serving hospitals and ICUs via enterprise subscriptions and home patients via Ministry of Health-subsidized distribution.

What EyeControl does

EyeControl (legally Eyefree Assisting Communication Ltd.) is an Israel-based medical device company founded in 2016 that builds an adaptive communication platform combining specialized hardware and software for patients who cannot speak due to intubation, sedation, or neurological conditions such as ALS. The platform consists of a wearable headset that pairs bone conduction audio with an AI-assisted infrared eye-tracking camera, a bedside tablet hub that delivers interventions under sedation and supports active engagement during recovery, and a secure Family App for message, photo, and music sharing. The system requires no calibration, supports multilingual communication including cross-language input/output, and operates 24/7 with seamless sleep-mode transitions.

The company operates two distinct go-to-market motions. For hospitals and ICUs, EyeControl sells a platform subscription/licensing model with on-the-ground Clinical Product Specialists handling implementation, training, and adoption at the bedside. Named enterprise customers include major Israeli hospitals (Rabin/Beilinson, Assuta, Meir, Tel Aviv Sourasky, PIC), all four major Israeli HMOs (Clalit, Maccabi, Meuhedet, Leumit), and in the United States, Northwell Health. For ALS and degenerative-disease patients at home, the EyeControl Home product is distributed via field specialists and is fully subsidized by Israel's Ministry of Health, removing patient cost.

The business generates revenue from healthcare-facility subscriptions and from hardware sales (the headset and bedside tablet). EyeControl holds FDA 21 CFR Part 11 clearance, ISO 27001, HIPAA, and GDPR compliance, and has raised approximately $15.3M across disclosed rounds from investors including Connecticut Innovations, the European Innovation Council, BIRD Foundation, Menomadin Foundation, and ZORA Ventures.

EyeControl firmographics

Firmographics
Name
EyeControl
Legal name
Eyefree Assisting Communication Ltd.
Website
https://eyecontrol.co.il
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
EyeControl is an Israel-based medical device company that builds AI-assisted eye-tracking headsets and bedside communication software enabling intubated, sedated, and ALS patients to communicate, serving hospitals and ICUs via enterprise subscriptions and home patients via Ministry of Health-subsidized distribution.
Ownership category
akta.pro rank

EyeControl industry classification

Industry
Product category
Medical Communication Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Computer Peripheral Equipment, Nec (3577)
akta.pro industry
PRIMARYHDACAFAL
Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards)
Hardware, Technology & Telecom/Computing Hardware & Peripherals/Input Devices & Accessories (Keyboards, Mice, Controllers)
SECONDARYHDACALAH
Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount)

Keywords

  • Eye-tracking communication
  • Medical assistive technology
  • ICU patient communication
  • ALS communication devices
  • Wearable healthcare devices

Where EyeControl is headquartered

Location

Headquarters

HQ city
Tel Aviv
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

EyeControl business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Healthcare Facility Licenses/Subscriptions: Platform licensing or subscription model to hospitals and healthcare facilities for ICU and critical care communication support
  2. EyeControl Home (Consumer/Home Health): Direct-to-patient home communication solution for ALS patients, subsidized by Israel's Ministry of Health
  3. Hardware (Headset): Specialized headset device combining bone conduction audio with eye-tracking technology

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEyeControl Home - Ministry of Health Subsidized

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

EyeControl product offering

Product offering

Core offering

EyeControl develops an adaptive communication platform combining specialized wearable hardware (a headset with bone conduction audio and AI-powered infrared eye-tracking camera) with bedside tablet and family mobile app software. The platform enables patients who cannot speak due to intubation, sedation, ALS, or other neurological conditions to communicate through eye gestures, scan audio-based menus, and connect with medical teams and families across ICU/critical care and home environments.

Product overview

EyeControl offers a unified adaptive communication platform designed for critical care and home use. The platform consists of specialized hardware components (Headset with bone conduction audio and AI-powered eye tracking, Bedside Tablet) and software (Family App) that work together to enable patients with complex needs to communicate. EyeControl Home extends the solution for home use by ALS patients. The platform supports patients from sedation through rehabilitation, providing 24/7 assistance with personalized and adaptable interaction modes.

Differentiator

Problem solved

Functional benefit

Brands

  • EyeControl Home: Communication solution for patients with ALS and other degenerative diseases, fully subsidized by the Ministry of Health.

Products and services

  • EyeControl Platform An adaptive communication platform combining specialized hardware (headset with bone conduction audio and AI-powered eye tracking, bedside tablet) and software (Family App) that supports patients from sedation through rehabilitation across hospital and home environments. Designed for ICU/critical care teams and patients with complex communication needs.
  • EyeControl Headset A wearable FDA-cleared medical device combining bone conduction audio with an infrared eye-tracking camera to detect patient awareness and enable hands-free communication responses through eye gestures for sedated, intubated, or neurologically impaired patients.
  • EyeControl Bedside Tablet

Quantifiable outcome

  • Reduces ICU patient agitation through calming input and communication
  • +3 more outcomes

Companies that use EyeControl

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

EyeControl technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

EyeControl partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Ministry of Health (Israel)coreStrategic or Co-development PartnerIsraeli government health ministry subsidizes EyeControl Home solution for ALS patients, making it free for qualifying patients
  • HCA HealthcareminorStrategic or Co-development PartnerAdvisory board member Karen H. Thompson serves as AVP of Regional Community Engagement at HCA Healthcare
  • Baylor University Medical CenterminorStrategic or Co-development PartnerAdvisory board member Dr. Ariel Modrykamien serves at Medical ICU of Baylor University Medical Center
  • Tel Aviv Sourasky Medical CenterminorStrategic or Co-development PartnerAdvisory board member Prof. Vivian Drory is a neurologist at Tel Aviv Sourasky Medical Center

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

EyeControl competitors and assessment

Company assessment

Broad incumbents

  • Vocera Communications (Stryker): Vocera (acquired by Stryker) provides secure hands-free clinical communication and alarm management for hospitals, including ICU workflows. Broad incumbent in hospital clinical communication with overlapping ICU patient/staff communication use cases, though not focused on eye-tracking-based patient output.
  • Hillrom / Baxter Patient Communication: Baxter (after acquiring Hillrom/Voalte) offers Voalte and Hillrom bedside communication platforms deployed in hospitals. Broad incumbent in hospital patient/staff communication infrastructure with overlapping ICU and patient-engagement applications.
  • Tobii AB (Tech division): Tobii AB, the parent of Tobii Dynavox, develops eye-tracking hardware and platforms across healthcare, research, and consumer applications. Comparable as an enabling technology supplier and broader eye-tracking presence.

Direct peers

  • EyeTech Digital Systems: EyeTech Digital Systems manufactures eye-tracking hardware and AAC integration solutions used in assistive communication and clinical research. Direct overlap in eye-tracking component technology for communication applications.
  • PRC-Saltillo: PRC-Saltillo (Prentke Romich Company / Saltillo) sells AAC devices including eye-tracking-based communicators (e.g., Accent 1000 with NuEye) for individuals with speech disabilities. Directly comparable to EyeControl in providing eye-gaze AAC solutions to non-speaking patients.
  • Lingraphica: Lingraphica provides AAC devices and apps primarily for adults with aphasia and other communication disorders, often reimbursed through US insurance. Comparable in delivering speech-generating devices to non-verbal adult populations.
  • Tobii Dynavox: Tobii Dynavox is the dominant dedicated AAC (augmentative and alternative communication) vendor using eye-tracking hardware (Tobii eye trackers) and dedicated software for non-speaking individuals with ALS, cerebral palsy, and other conditions. It is the most direct competitor to EyeControl on assistive eye-tracking communication.
  • Smartbox Assistive Technology: Smartbox (Grid/Communicator product line) builds AAC hardware and software, including eye-gaze-enabled devices for people with complex communication needs. Highly comparable in target population and modality.
  • LC Technologies: LC Technologies (Eyegaze Edge) builds eye-tracking-based AAC systems for non-verbal users including those with ALS and locked-in syndrome. Direct peer in eye-gaze communication hardware and software.

Emerging players

  • AssistiveWare: AssistiveWare produces Proloquo and Keeble AAC software, primarily on iPad, focused on autism, cerebral palsy, and progressive conditions. Less hardware-specialized than EyeControl but addresses a similar communication-needs population with iOS-based tools.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

EyeControl social profiles

Digital presence

EyeControl compliance and trust

Trust signal

Compliance4 records

EyeControl financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EyeControl leadership team

Management profile

Number of profiles

Profiles1 record

EyeControl funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EyeControl M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EyeControl

What does EyeControl do?

EyeControl develops an adaptive communication platform combining specialized wearable hardware (a headset with bone conduction audio and AI-powered infrared eye-tracking camera) with bedside tablet and family mobile app software. The platform enables patients who cannot speak due to intubation, sedation, ALS, or other neurological conditions to communicate through eye gestures, scan audio-based menus, and connect with medical teams and families across ICU/critical care and home environments.

Is EyeControl a public or private company?

EyeControl is a private company. It is classified as venture growth investor backed and is currently operating.

When was EyeControl founded?

EyeControl was founded in 2016. It employs 11 to 50 people.

Where is EyeControl based?

EyeControl is headquartered in Tel Aviv, Israel, in the Middle East region.

How does EyeControl make money?

Three revenue lines are on record. Healthcare Facility Licenses/Subscriptions are the primary driver. The others are eyeControl Home (Consumer/Home Health) and hardware (Headset).

Who are EyeControl's main competitors?

Broad incumbents on record are Vocera Communications (Stryker), Hillrom / Baxter Patient Communication and Tobii AB (Tech division). Direct peers are EyeTech Digital Systems, PRC-Saltillo, Lingraphica, Tobii Dynavox, Smartbox Assistive Technology and LC Technologies. AssistiveWare is listed as an emerging player.

Does EyeControl have an API?

No public API is recorded for EyeControl.

What industry is EyeControl in?

EyeControl's product category is Medical Communication Devices. Its primary akta.pro industry code is HDACAFAL, Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards), with a secondary code of HDACALAH, Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CTech"The system detects bleeding in the brain before the doctor even sees it"Healthcare professionals at the Future of Industry conference discussed how artificial intelligence is reshaping clinical practice, with speakers arguing that the intersection of medicine and technology is creating demand for multidisciplinary professionals. Aidoc, a medical AI company, demonstrated how its technology detects brain hemorrhages and other critical conditions in CT scans before radiologists review them, operating in over 2,000 hospitals and analyzing more than 60 million scans annually. Additional speakers highlighted AI applications in preventive medicine at Maccabi Health Services and AI-powered communication devices for ALS patients developed by EyeControl.HaaretzTalking to the Unconscious: Israelis Reduce Delirium During SurgeryEyeControl's device, a headband with earphone and camera, helps ICU patients communicate while sedated, reducing delirium. The company plans a 160-patient trial over 18 months, with a parallel trial at Johns Hopkins. The device is sold to hospitals for $3,000–$5,000.PR NewswireEyeControl Expands R&D Program with EyeControl-Pro for DeliriumEyeControl is expanding its R&D program with EyeControl-Pro, an AI-based wearable eye-tracking device for delirium reduction, and will exhibit it at the American Delirium Society Conference in Indianapolis. The company will share early clinical trial data showing decreased patient errors and improved communication scores. The device is investigational and not FDA cleared.Business StandardOver 100,000 Zyxel firewalls, VPN gateways at hacking risk: ReportDutch researchers from Eye Control discovered a hardcoded backdoor account in over 100,000 Zyxel firewalls, VPN gateways, and access point controllers. The vulnerability grants access to business-grade devices used in enterprise and government networks. Zyxel issued a security patch and advised users to install firmware updates.FinSMEsEyeControl Secures $10M in FundingEyeControl, a Tel Aviv-based assistive communication device maker, raised $10M in a Series A led by Connecticut Innovations. The funding will expand hospital activity and strategic partnerships. The company also appointed Avner Halperin as chairman of its expanded board.PrwebEyeControl Secures $10 Million from COVID-19 Pilot Program & Series A Round Investments to Commercialize AI-Powered Communication Solution for Ventilated ICU PatientsEyeControl closed a Series A round and won the EIC COVID-19 Pilot Program, securing over $10M in combined funding. The company, which makes AI-powered eye-tracking communication devices for ventilated ICU patients, will use the funds to expand hospital activity and partnerships. Avner Halperin was appointed chairman of its expanded board.